Claire Rempenault
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis.
Journal: Joint bone spine
Published: July 15, 2024
Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory disease.
Journal: RMD open
Published: June 20, 2023
CXCR5/CXCL13 pathway, a key driver for migration of regulatory B10 cells, is defective in patients with rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: January 28, 2021
Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept.
Journal: Rheumatology (Oxford, England)
Published: January 14, 2021
Treatment of bone and joint infections by ceftazidime/avibactam and ceftolozane/tazobactam: a cohort study.
Journal: Journal of global antimicrobial resistance
Published: April 05, 2020
Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review.
Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review.
Journal: Arthritis care & research
Published: August 24, 2018
Response to: 'Cardiovascular effects of hydroxychloroquine: a systematic review and meta-analysis' by Mathieu et al.
Journal: Annals of the rheumatic diseases
Published: November 01, 2017
Response to: 'Metabolic and cardiovascular benefits of hydroxychloroquine: exploration in a wider population at high CV risk' by Pareek et al.
Journal: Annals of the rheumatic diseases
Published: October 17, 2017
Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
Journal: Annals of the rheumatic diseases
Published: May 24, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026